MTOR and fatty liver disease: Secondary biliary acids produced by the metabolic activity of the gut microbiota are also able to enhance AKT-independent mTOR activity in the liver to promote hepatic steatosis and HCC, while depleting gut microbiota with antibiotics reverses these mechanisms [51].